Cephia D Toomer
Examiner (ID: 3951, Phone: (571)272-1126 , Office: P/1771 )
Most Active Art Unit | 1771 |
Art Unit(s) | 1797, 1771, 1721, 1714, 1111 |
Total Applications | 2905 |
Issued Applications | 1874 |
Pending Applications | 316 |
Abandoned Applications | 715 |
Applications
Application number | Title of the application | Filing Date | Status |
---|---|---|---|
Array
(
[id] => 5661054
[patent_doc_number] => 20060251650
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-11-09
[patent_title] => 'Antagonists of neuroplin receptor function and use thereof'
[patent_app_type] => utility
[patent_app_number] => 11/488364
[patent_app_country] => US
[patent_app_date] => 2006-07-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 30
[patent_figures_cnt] => 30
[patent_no_of_words] => 17360
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0251/20060251650.pdf
[firstpage_image] =>[orig_patent_app_number] => 11488364
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/488364 | Antagonists of neuropilin receptor function and use thereof | Jul 17, 2006 | Issued |
Array
(
[id] => 5079630
[patent_doc_number] => 20070122854
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-05-31
[patent_title] => 'Method for diagnosing colon cancer'
[patent_app_type] => utility
[patent_app_number] => 11/291147
[patent_app_country] => US
[patent_app_date] => 2005-11-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 4536
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0122/20070122854.pdf
[firstpage_image] =>[orig_patent_app_number] => 11291147
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/291147 | Method for diagnosing colon cancer | Nov 28, 2005 | Abandoned |
Array
(
[id] => 386497
[patent_doc_number] => 07303866
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2007-12-04
[patent_title] => 'Methods of identifying an agent that modulates an interaction between 53BP1 and histone H3, and uses thereof'
[patent_app_type] => utility
[patent_app_number] => 11/253190
[patent_app_country] => US
[patent_app_date] => 2005-10-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 13452
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 160
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/303/07303866.pdf
[firstpage_image] =>[orig_patent_app_number] => 11253190
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/253190 | Methods of identifying an agent that modulates an interaction between 53BP1 and histone H3, and uses thereof | Oct 16, 2005 | Issued |
Array
(
[id] => 6977444
[patent_doc_number] => 20050287160
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-12-29
[patent_title] => 'HLA-A24 binding peptides of enhancer of zeste homolog 2'
[patent_app_type] => utility
[patent_app_number] => 11/208541
[patent_app_country] => US
[patent_app_date] => 2005-08-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 5770
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0287/20050287160.pdf
[firstpage_image] =>[orig_patent_app_number] => 11208541
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/208541 | HLA-A24 binding peptides of enhancer of zeste homolog 2 | Aug 22, 2005 | Issued |
Array
(
[id] => 5766777
[patent_doc_number] => 20060018901
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-01-26
[patent_title] => 'Use of antibodies in a very low dose for the vaccination against cancer'
[patent_app_type] => utility
[patent_app_number] => 11/185299
[patent_app_country] => US
[patent_app_date] => 2005-07-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 7306
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0018/20060018901.pdf
[firstpage_image] =>[orig_patent_app_number] => 11185299
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/185299 | Use of antibodies in a very low dose for the vaccination against cancer | Jul 19, 2005 | Abandoned |
Array
(
[id] => 5813147
[patent_doc_number] => 20060083743
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-04-20
[patent_title] => 'Method of cancer therapy by in situ production of F5 antibodies'
[patent_app_type] => utility
[patent_app_number] => 11/143735
[patent_app_country] => US
[patent_app_date] => 2005-06-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 47
[patent_figures_cnt] => 47
[patent_no_of_words] => 19264
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 11143735
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/143735 | Method of cancer therapy by in situ production of F5 antibodies | Jun 2, 2005 | Abandoned |
60/813610 | Preparation of a peptide compound (SYRAPRO-2000) and its use for the activation of protein phosphatase-2A1 enzyme | May 3, 2005 | Pending |
Array
(
[id] => 5793987
[patent_doc_number] => 20060014668
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-01-19
[patent_title] => 'Antigenic gp 100 compounds for therapy and diagnosis and methods of using same'
[patent_app_type] => utility
[patent_app_number] => 11/119502
[patent_app_country] => US
[patent_app_date] => 2005-04-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 23449
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0014/20060014668.pdf
[firstpage_image] =>[orig_patent_app_number] => 11119502
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/119502 | Antigenic gp 100 compounds for therapy and diagnosis and methods of using same | Apr 28, 2005 | Abandoned |
11/090437 | Methods of diagnosing, preventing and treating cancer metastasis | Mar 24, 2005 | Abandoned |
Array
(
[id] => 7068950
[patent_doc_number] => 20050244333
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-11-03
[patent_title] => 'Humanized anti-CEA T84.66 antibody and uses thereof'
[patent_app_type] => utility
[patent_app_number] => 11/077978
[patent_app_country] => US
[patent_app_date] => 2005-03-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 10669
[patent_no_of_claims] => 38
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0244/20050244333.pdf
[firstpage_image] =>[orig_patent_app_number] => 11077978
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/077978 | Humanized anti-CEA T84.66 antibody and uses thereof | Mar 10, 2005 | Issued |
Array
(
[id] => 7216890
[patent_doc_number] => 20050260217
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-11-24
[patent_title] => 'Co-encapsulated WT1 polypeptide and immunostimulant microsphere formulations and methods thereof'
[patent_app_type] => utility
[patent_app_number] => 11/071062
[patent_app_country] => US
[patent_app_date] => 2005-03-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11658
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0260/20050260217.pdf
[firstpage_image] =>[orig_patent_app_number] => 11071062
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/071062 | Co-encapsulated WT1 polypeptide and immunostimulant microsphere formulations and methods thereof | Mar 2, 2005 | Abandoned |
Array
(
[id] => 7169718
[patent_doc_number] => 20050202485
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-09-15
[patent_title] => 'Method and compositions for detection of liver cancer'
[patent_app_type] => utility
[patent_app_number] => 11/064760
[patent_app_country] => US
[patent_app_date] => 2005-02-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 5636
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0202/20050202485.pdf
[firstpage_image] =>[orig_patent_app_number] => 11064760
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/064760 | Method and compositions for detection of liver cancer | Feb 22, 2005 | Abandoned |
Array
(
[id] => 7050717
[patent_doc_number] => 20050186604
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-08-25
[patent_title] => 'Aberrant Myc/TIP60 interactions as a target for anti-cancer therapeutics'
[patent_app_type] => utility
[patent_app_number] => 11/044865
[patent_app_country] => US
[patent_app_date] => 2005-01-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 33
[patent_figures_cnt] => 33
[patent_no_of_words] => 13754
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0186/20050186604.pdf
[firstpage_image] =>[orig_patent_app_number] => 11044865
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/044865 | Aberrant Myc/TIP60 interactions as a target for anti-cancer therapeutics | Jan 26, 2005 | Abandoned |
Array
(
[id] => 6983282
[patent_doc_number] => 20050153352
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-07-14
[patent_title] => 'Cancer specific gene MG20'
[patent_app_type] => utility
[patent_app_number] => 11/031922
[patent_app_country] => US
[patent_app_date] => 2005-01-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 14
[patent_figures_cnt] => 14
[patent_no_of_words] => 13795
[patent_no_of_claims] => 57
[patent_no_of_ind_claims] => 16
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0153/20050153352.pdf
[firstpage_image] =>[orig_patent_app_number] => 11031922
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/031922 | Cancer specific gene MG20 | Jan 6, 2005 | Abandoned |
Array
(
[id] => 6951775
[patent_doc_number] => 20050226869
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-10-13
[patent_title] => 'Compositions and methods for the treatment of tumor of hematopoietic origin'
[patent_app_type] => utility
[patent_app_number] => 11/020508
[patent_app_country] => US
[patent_app_date] => 2004-12-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 41
[patent_figures_cnt] => 41
[patent_no_of_words] => 74191
[patent_no_of_claims] => 63
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0226/20050226869.pdf
[firstpage_image] =>[orig_patent_app_number] => 11020508
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/020508 | Compositions and methods for the treatment of tumor of hematopoietic origin | Dec 20, 2004 | Abandoned |
Array
(
[id] => 5771571
[patent_doc_number] => 20050267022
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-12-01
[patent_title] => 'Identification of novel factors that block programmed cell death or apoptosis by targeting JNK'
[patent_app_type] => utility
[patent_app_number] => 11/000365
[patent_app_country] => US
[patent_app_date] => 2004-11-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 42
[patent_figures_cnt] => 42
[patent_no_of_words] => 37756
[patent_no_of_claims] => 28
[patent_no_of_ind_claims] => 15
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0267/20050267022.pdf
[firstpage_image] =>[orig_patent_app_number] => 11000365
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/000365 | Identification of novel factors that block programmed cell death or apoptosis by targeting JNK | Nov 28, 2004 | Issued |
Array
(
[id] => 7110603
[patent_doc_number] => 20050208058
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-09-22
[patent_title] => 'Compositions and methods for modulating cell division'
[patent_app_type] => utility
[patent_app_number] => 10/995795
[patent_app_country] => US
[patent_app_date] => 2004-11-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 17587
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0208/20050208058.pdf
[firstpage_image] =>[orig_patent_app_number] => 10995795
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/995795 | Compositions and methods for modulating cell division | Nov 21, 2004 | Abandoned |
Array
(
[id] => 6912317
[patent_doc_number] => 20050176075
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-08-11
[patent_title] => 'Mdm2 splice variants'
[patent_app_type] => utility
[patent_app_number] => 10/980519
[patent_app_country] => US
[patent_app_date] => 2004-11-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 20290
[patent_no_of_claims] => 29
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0176/20050176075.pdf
[firstpage_image] =>[orig_patent_app_number] => 10980519
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/980519 | Mdm2 splice variants | Nov 2, 2004 | Issued |
Array
(
[id] => 7252115
[patent_doc_number] => 20050142538
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-06-30
[patent_title] => 'Viral receptor protein'
[patent_app_type] => utility
[patent_app_number] => 10/926337
[patent_app_country] => US
[patent_app_date] => 2004-08-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 19313
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0142/20050142538.pdf
[firstpage_image] =>[orig_patent_app_number] => 10926337
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/926337 | Viral receptor protein | Aug 25, 2004 | Abandoned |
Array
(
[id] => 6990859
[patent_doc_number] => 20050089896
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-04-28
[patent_title] => 'Method to control tumor progression and invasiveness'
[patent_app_type] => utility
[patent_app_number] => 10/923543
[patent_app_country] => US
[patent_app_date] => 2004-08-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 15
[patent_figures_cnt] => 15
[patent_no_of_words] => 13480
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 10
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0089/20050089896.pdf
[firstpage_image] =>[orig_patent_app_number] => 10923543
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/923543 | Method to control tumor progression and invasiveness | Aug 19, 2004 | Abandoned |